Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Finished Drug Prices
NA
1. 1138245-21-2
2. Mirogabalin Besilate
3. Mirogabalin Besylate [usan]
4. 01f4frp8yl
5. 2-[(1r,5s,6s)-6-(aminomethyl)-3-ethyl-6-bicyclo[3.2.0]hept-3-enyl]acetic Acid;benzenesulfonic Acid
6. Mirogabalin Besilate (jan)
7. Mirogabalin Besylate (usan)
8. 2-((1r,5s,6s)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic Acid Compound With Benzenesulfonic Acid (1:1)
9. Bicyclo(3.2.0)hept-3-ene-6-acetic Acid, 6-(aminomethyl)-3-ethyl-, (1r,5s,6s)-, Benzenesulfonate (1:1)
10. Mirogabalin Besilate [jan]
11. Unii-01f4frp8yl
12. Mirogabalin Besilate [who-dd]
13. Schembl1883872
14. Chembl3545257
15. Amy16760
16. Ex-a2817
17. Mfcd31631215
18. Ac-30336
19. Hy-108006
20. Cs-0027136
21. D10790
22. A901402
23. 2-((1r,5s,6s)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic Acid Besylate
24. 2-((1r,5s,6s)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)aceticacidbesylate
25. ((1r,5s,6s)-6-(aminomethyl)-3-ethylbicyclo(3.2.0)hept-3-en-6-yl)acetic Acid Monobenzenesulfonate
26. [(1r,5s,6s)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl]acetic Acid Benzenesulfonate;
Molecular Weight | 367.5 g/mol |
---|---|
Molecular Formula | C18H25NO5S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 5 |
Exact Mass | 367.14534407 g/mol |
Monoisotopic Mass | 367.14534407 g/mol |
Topological Polar Surface Area | 126 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 494 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39342
Submission : 2023-12-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38908
Submission : 2023-09-20
Status : Active
Type : II
Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2024-07-17
Registration Number : Thu21-27-ND(1)
Manufacturer Name : Lee Pharma Limited
Manufacturer Address : Survey No.10/G-1, Gaddapotharam Village, Jinnaram Mandal, Sangareddy District, Telangana State, 502319, India
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39342
Submission : 2023-12-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38908
Submission : 2023-09-20
Status : Active
Type : II
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product ...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
About the Company : Ami Lifesciences, established in 2006, is one of the fastest growing API manufacturing companies in India. Specializing in cardiovascular, anti-diabetic, CNS, and respiratory thera...
About the Company : Aptra Synthesis Private Limited, is a reliable and vertically integrated manufacturer of APIs and intermediates, boasting state-of-the-art manufacturing facilities that adhere to G...
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
About the Company : Ceyone Life Sciences specializes in providing research-oriented chemistry services and manufacturing niche chemicals, intermediates, and APIs. The company is focused on offering co...
About the Company : Lee helps you focus on the business results that matter to your company. Over the years, we have leveraged our position in the global market with an enviable list of clients and a ...
About the Company : Prajna is an innovation driven pharmaceutical company. We dedicated to Research, Process development and Manufacturing APIs and Advanced Intermediates for Active Pharmaceutical Ing...
About the Company : Sichuan Qingmu Pharmaceutical Co., Ltd, is a FDA approved cGMP factory in China, focusing on APIs’ production. The products are mainly Oncology APIs, Cardiovascular APIs, and Vet...
About the Company : Zhejiang Bamboo Pharmaceuticals is a new, innovative, green, high-grade pharmaceutical intermediate, API and oral solid formulation pharmaceutical manufacturer which was establishe...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Tarlige® (mirogabalin besilate), is an analgesic works by inhibiting the excessive release of pain-related neurotransmitters in presynaptic nerve terminal, ® was approved for the indication of “peripheral neuropathic pain” in Japan.
Lead Product(s): Mirogabalin Besylate
Therapeutic Area: Neurology Brand Name: Tarlige
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 28, 2022
Lead Product(s) : Mirogabalin Besylate
Therapeutic Area : Neurology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Tarlige® Tablets Approved in Japan for Treatment of Patients with Neuropathic Pain
Details : Tarlige® (mirogabalin besilate), is an analgesic works by inhibiting the excessive release of pain-related neurotransmitters in presynaptic nerve terminal, ® was approved for the indication of “peripheral neuropathic pain” in Japan.
Brand Name : Tarlige
Molecule Type : Small molecule
Upfront Cash : Not Applicable
March 28, 2022
(1R,5S)-3-ethylbicyclo[3.2.0]hept-3- en-6-one
CAS Number : 1235479-61-4
End Use API : Mirogabalin Besylate
About The Company : Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & ope...
(1R,5S)-3-ethyl-Bicyclo[3.2.0]hept-3-en-6-one
CAS Number : 1235479-61-4
End Use API : Mirogabalin Besylate
About The Company : Prajna is an innovation driven pharmaceutical company. We dedicated to Research, Process development and Manufacturing APIs and Advanced Intermediates for Activ...
Regulatory Info :
Registration Country : Egypt
Brand Name : Gabalihochs
Dosage Form : Orally Disintegrated Tablet
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Egypt
Global Sales Information
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 165
2019 Revenue in Millions : 49
Growth (%) : 233
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 237
2020 Revenue in Millions : 164
Growth (%) : 56
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 280
2021 Revenue in Millions : 237
Growth (%) : 18
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 304
2022 Revenue in Millions : 280
Growth (%) : 23
Market Place
Reply
20 Dec 2024
Reply
02 Nov 2023
Reply
02 Jun 2023
Reply
12 Oct 2020
ABOUT THIS PAGE
A Mirogabalin Besilate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mirogabalin Besilate, including repackagers and relabelers. The FDA regulates Mirogabalin Besilate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mirogabalin Besilate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mirogabalin Besilate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mirogabalin Besilate supplier is an individual or a company that provides Mirogabalin Besilate active pharmaceutical ingredient (API) or Mirogabalin Besilate finished formulations upon request. The Mirogabalin Besilate suppliers may include Mirogabalin Besilate API manufacturers, exporters, distributors and traders.
click here to find a list of Mirogabalin Besilate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mirogabalin Besilate DMF (Drug Master File) is a document detailing the whole manufacturing process of Mirogabalin Besilate active pharmaceutical ingredient (API) in detail. Different forms of Mirogabalin Besilate DMFs exist exist since differing nations have different regulations, such as Mirogabalin Besilate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mirogabalin Besilate DMF submitted to regulatory agencies in the US is known as a USDMF. Mirogabalin Besilate USDMF includes data on Mirogabalin Besilate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mirogabalin Besilate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mirogabalin Besilate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Mirogabalin Besilate Drug Master File in Korea (Mirogabalin Besilate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Mirogabalin Besilate. The MFDS reviews the Mirogabalin Besilate KDMF as part of the drug registration process and uses the information provided in the Mirogabalin Besilate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Mirogabalin Besilate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Mirogabalin Besilate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Mirogabalin Besilate suppliers with KDMF on PharmaCompass.
Mirogabalin Besilate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mirogabalin Besilate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mirogabalin Besilate GMP manufacturer or Mirogabalin Besilate GMP API supplier for your needs.
A Mirogabalin Besilate CoA (Certificate of Analysis) is a formal document that attests to Mirogabalin Besilate's compliance with Mirogabalin Besilate specifications and serves as a tool for batch-level quality control.
Mirogabalin Besilate CoA mostly includes findings from lab analyses of a specific batch. For each Mirogabalin Besilate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mirogabalin Besilate may be tested according to a variety of international standards, such as European Pharmacopoeia (Mirogabalin Besilate EP), Mirogabalin Besilate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mirogabalin Besilate USP).
LOOKING FOR A SUPPLIER?